Expert: FDA guidance for Alzheimer's drugs should help industry

02/9/2013 | Columbus Dispatch (Ohio), The

New draft guidance for the development of drugs targeting the early stages of Alzheimer's disease will assist drugmakers with the design of clinical trials aimed at detecting disease before the onset of dementia, said Dr. Paul Aisen, director of the Alzheimer's Disease Cooperative Study. "I think this will be hugely useful to the pharmaceutical industry," he said.

View Full Article in:

Columbus Dispatch (Ohio), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Paralegal
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA